Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictors of OAB Symptom Relapse After Tolterodine Discontinuation
NCT00730535Phase 4Completed
- Start
- Aug 2006
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tolterodine in overactive bladder (OAB). Started Aug 2006; status: completed.
02
Drugs
tolterodine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00730535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00730535.